vialaudit
MELANOTAN I·FLORIDA·LAST CHECKED 1 NOV 2026

Is Melanotan I legal in Florida?

CAVEATS APPLY

We found no Florida statute, board rule or enforcement action that names Melanotan I, so federal law applies. Yes, as a prescription drug: FDA has approved it (Scenesse). A vial sold as a 'research peptide' is not the approved product, and selling it for human use breaks federal drug law. Pharmacies may compound it only when the product is not a copy of the approved drug.

CATEGORY · APPROVED DRUG DIVERSION

Full status breakdown

FEDERAL · STATE · SPORT-BODY

Federal status

FDA approval
approved as drug · brand: Scenesse · NDA 210797 · approved Oct 8, 2019
Indications: Increase pain-free light exposure in adults with erythropoietic protoporphyria (EPP)
DEA scheduling
not scheduled
503A compounding
FDA interim category: Component of an FDA-approved drug
503A Bulks List: not on list
Afamelanotide is the active ingredient of Scenesse, an implant given by a health professional. 503A rules on approved components and 'essentially a copy' apply; we found no FDA statement on compounded afamelanotide.
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Critical cross-reference: Afamelanotide = Melanotan I = Scenesse. Vendors selling lyophilized 'Melanotan I' powder for SC injection are selling the same molecule as Scenesse, just a different dose form. This is FDCA §505 unapproved drug + §301 misbranding + potential §304 anti-counterfeiting.
Personal possession: Not federally criminalized.

Florida — state-specific

Sport-body status

WADA 2026
not prohibited
Afamelanotide is an approved drug (Scenesse), so S0 does not apply, and melanocortin agonists are not otherwise listed.
USADA
not banned
NCAA
unknown

What we couldn’t verify

Also known as

6 ALIASES

Melanotan I is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • Afamelanotide
  • Scenesse
  • MT-1
  • Melanotan-I
  • CUV1647
  • NDA 210797

Related

FOLLOW-ONS

Melanotan I: US status, sources and what changed

THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH